Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × Pharmaceutical Preparations × Clear all

NCT00210392 2015-03-30

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

Phase 2 Terminated

Lymphoma, B-Cell, Marginal Zone

NCT00210327 2009-07-22

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Phase 2 Completed

Lymphoma, B-Cell, Marginal Zone